SKP acquires 40.2% of RTP

By BC Staff | Aug 1, 2001 | 7:00 AM GMT

Drug delivery play SkyePharma (LSE:SKP;SKYE) acquired a 40.2% stake in nanoparticle technology company RTP Pharma (Toronto, Ontario).

Read the full 173 word article

How to gain access

Continue reading with a
two-week free trial.